Patterns of somatically acquired amplifications and deletions in apparently normal tissues of ovarian cancer patients

Cell Reports

Volumn 7, Issue 4, 2014, Pages 1310-1319

  Aghili, Leila ^a   Foo, Jasmine ^b   DeGregori, James ^a,c   De, Subhajyoti ^a,c,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b University of Minnesota   (United States)

^c UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^d Global Health and Health Disparities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE QUADRUPLEX;

ALU SEQUENCE; ARTICLE; CANCER GENETICS; CANCER SURVIVAL; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MAPPING; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; BLOOD; CASE CONTROL STUDY; GENE DOSAGE; GENETICS; GENOMICS; LUNG TUMOR; MUTATION; OVARY TUMOR; PROCEDURES; AGE DISTRIBUTION; AGING; BLOOD SAMPLING; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CELL DIVISION; DIAGNOSTIC TEST ACCURACY STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MUTATION; HUMAN CELL; ONCOGENE; ONCOGENE BRCA; PREDICTIVE VALUE; PREVALENCE; SIGNAL TRANSDUCTION; SOMATIC CELL GENETICS; SOMATIC COPY NUMBER ALTERATION;

CASE-CONTROL STUDIES; DNA COPY NUMBER VARIATIONS; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENOMICS; HUMANS; LUNG NEOPLASMS; MUTATION; OVARIAN NEOPLASMS; SEQUENCE DELETION;

EID: 84901280239     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.03.071     Document Type: Article

References (61)

1. Abyzov A., Mariani J., Palejev D., Zhang Y., Haney M.S., Tomasini L., Ferrandino A.F., Rosenberg Belmaker L.A., Szekely A., Wilson M., et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 2012, 492:438-442.
2. Araten D.J., Golde D.W., Zhang R.H., Thaler H.T., Gargiulo L., Notaro R., Luzzatto L. A quantitative measurement of the human somatic mutation rate. Cancer Res. 2005, 65:8111-8117.
3. Bannert N., Vollhardt K., Asomuddinov B., Haag M., König H., Norley S., Kurth R. PDZ Domain-mediated interaction of interleukin-16 precursor proteins with myosin phosphatase targeting subunits. J. Biol. Chem. 2003, 278:42190-42199.
4. Barlow J.H., Faryabi R.B., Callén E., Wong N., Malhowski A., Chen H.T., Gutierrez-Cruz G., Sun H.W., McKinnon P., Wright G., et al. Identification of early replicating fragile sites that contribute to genome instability. Cell 2013, 152:620-632.
5. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., Barretina J., Boehm J.S., Dobson J., Urashima M., et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
6. Biesecker L.G., Spinner N.B. A genomic view of mosaicism and human disease. Nat. Rev. Genet. 2013, 14:307-320.
7. Bonnefond A., Skrobek B., Lobbens S., Eury E., Thuillier D., Cauchi S., Lantieri O., Balkau B., Riboli E., Marre M., et al. Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications. Nat. Genet. 2013, 45:1040-1043.
8. Campbell C.D., Eichler E.E. Properties and rates of germline mutations in humans. Trends Genet. 2013, 29:575-584.
9. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615. Cancer Genome Atlas Research Network.
10. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012, 489:519-525. Cancer Genome Atlas Research Network.
11. Clemente M.J., Wlodarski M.W., Makishima H., Viny A.D., Bretschneider I., Shaik M., Bejanyan N., Lichtin A.E., Hsi E.D., Paquette R.L., et al. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood 2011, 118:4384-4393.
12. Collins F.S., Barker A.D. Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Sci. Am. 2007, 296:50-57.
13. De S. Somatic mosaicism in healthy human tissues. Trends Genet. 2011, 27:217-223.
14. De S., Michor F. DNA secondary structures and epigenetic determinants of cancer genome evolution. Nat. Struct. Mol. Biol. 2011, 18:950-955.
15. De S., Pedersen B.S., Kechris K. The dilemma of choosing the ideal permutation strategy while estimating statistical significance of genome-wide enrichment. Brief. Bioinform. 2013, Published online August 16, 2013. 10.1093/bib/bbt053.
16. DeGregori J. Evolved tumor suppression: why are we so good at not getting cancer?. Cancer Res. 2011, 71:3739-3744.
17. DeGregori J. Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?. Oncogene 2013, 32:1869-1875.
18. Dewannieux M., Esnault C., Heidmann T. LINE-mediated retrotransposition of marked Alu sequences. Nat. Genet. 2003, 35:41-48.
19. Durkin S.G., Glover T.W. Chromosome fragile sites. Annu. Rev. Genet. 2007, 41:169-192.
20. Elson J.L., Samuels D.C., Turnbull D.M., Chinnery P.F. Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am. J. Hum. Genet. 2001, 68:802-806.
21. Flicek P., Amode M.R., Barrell D., Beal K., Billis K., Brent S., Carvalho-Silva D., Clapham P., Coates G., Fitzgerald S., et al. Ensembl 2014. Nucleic Acids Res. 2014, 42(Database issue):D749-D755.
22. Friedenson B. The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers. BMC Cancer 2007, 7:152.
23. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
24. Hansen R.S., Thomas S., Sandstrom R., Canfield T.K., Thurman R.E., Weaver M., Dorschner M.O., Gartler S.M., Stamatoyannopoulos J.A. Sequencing newly replicated DNA reveals widespread plasticity in human replication timing. Proc. Natl. Acad. Sci. USA 2010, 107:139-144.
25. Huang C.Y., Tan T.H. DUSPs, to MAP kinases and beyond. Cell Biosci 2012, 2:24. 10.1186/2045-3701-2-24.
26. Hughes A.E., Orr N., Esfandiary H., Diaz-Torres M., Goodship T., Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 2006, 38:1173-1177.
27. Huppert J.L., Balasubramanian S. Prevalence of quadruplexes in the human genome. Nucleic Acids Res. 2005, 33:2908-2916.
28. Jacobs K.B., Yeager M., Zhou W., Wacholder S., Wang Z., Rodriguez-Santiago B., Hutchinson A., Deng X., Liu C., Horner M.J., et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nat. Genet. 2012, 44:651-658.
29. Kanchi K.L., Johnson K.J., Lu C., McLellan M.D., Leiserson M.D.M., Wendl M.C., Zhang Q., Koboldt D.C., Xie M., Kandoth C., et al. Integrated analysis of germline and somatic variants in ovarian cancer. Nature Commun. 2014, 5:3156.
30. Kano H., Godoy I., Courtney C., Vetter M.R., Gerton G.L., Ostertag E.M., Kazazian H.H. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev. 2009, 23:1303-1312.
31. Konishi H., Mohseni M., Tamaki A., Garay J.P., Croessmann S., Karnan S., Ota A., Wong H.Y., Konishi Y., Karakas B., et al. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc. Natl. Acad. Sci. USA 2011, 108:17773-17778.
32. Kruisselbrink E., Guryev V., Brouwer K., Pontier D.B., Cuppen E., Tijsterman M. Mutagenic capacity of endogenous G4 DNA underlies genome instability in FANCJ-defective C. elegans. Curr. Biol. 2008, 18:900-905.
33. Lam E.Y.N., Beraldi D., Tannahill D., Balasubramanian S. G-quadruplex structures are stable and detectable in human genomic DNA. Nature Commun. 2013, 4:1796.
34. Laurie C.C., Laurie C.A., Rice K., Doheny K.F., Zelnick L.R., McHugh C.P., Ling H., Hetrick K.N., Pugh E.W., Amos C., et al. Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat. Genet. 2012, 44:642-650.
35. Lupski J.R. Genomic rearrangements and sporadic disease. Nat. Genet. 2007, 39(7, Suppl):S43-S47.
36. Macia A., Muñoz-Lopez M., Cortes J.L., Hastings R.K., Morell S., Lucena-Aguilar G., Marchal J.A., Badge R.M., Garcia-Perez J.L. Epigenetic control of retrotransposon expression in human embryonic stem cells. Mol. Cell. Biol. 2011, 31:300-316.
37. Maizels N., Gray L.T. The G4 genome. PLoS Genet. 2013, 9:e1003468.
38. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
39. Maslov A.Y., Ganapathi S., Westerhof M., Quispe-Tintaya W., White R.R., Van Houten B., Reiling E., Dollé M.E., van Steeg H., Hasty P., et al. DNA damage in normally and prematurely aged mice. Aging Cell 2013, 12:467-477.
40. Matsuo M., Kaji K., Utakoji T., Hosoda K. Ploidy of human embryonic fibroblasts during in vitro aging. J. Gerontol. 1982, 37:33-37.
41. Meyer L.R., Zweig A.S., Hinrichs A.S., Karolchik D., Kuhn R.M., Wong M., Sloan C.A., Rosenbloom K.R., Roe G., Rhead B., et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res. 2013, 41(Database issue):D64-D69.
42. Miller W., Rosenbloom K., Hardison R.C., Hou M., Taylor J., Raney B., Burhans R., King D.C., Baertsch R., Blankenberg D., et al. 28-way vertebrate alignment and conservation track in the UCSC Genome Browser. Genome Res. 2007, 17:1797-1808.
43. Moran A., O'Hara C., Khan S., Shack L., Woodward E., Maher E.R., Lalloo F., Evans D.G. Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Fam. Cancer 2012, 11:235-242.
44. Pang A.W., Migita O., Macdonald J.R., Feuk L., Scherer S.W. Mechanisms of formation of structural variation in a fully sequenced human genome. Hum. Mutat. 2013, 34:345-354.
45. Pedersen B.S., De S. Loss of heterozygosity preferentially occurs in early replicating regions in cancer genomes. Nucleic Acids Res. 2013, 41:7615-7624.
46. Pedersen B.S., Konstantinopoulos P.A., Spillman M.A., De S. Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients. Genes Chromosomes Cancer 2013, 52:794-801.
47. Pedersen B.S., Yang I.V., De S. CruzDB: software for annotation of genomic intervals with UCSC genome-browser database. Bioinformatics 2013, 29:3003-3006.
48. Pham J., Shaw C., Pursley A., Hixson P., Sampath S., Roney E., Gambin T., Kang S.H., Bi W., Lalani S., et al. Somatic mosaicism detected by exon-targeted, high-resolution aCGH in 10 362 consecutive cases. Eur. J. Hum. Genet. 2014, Published online January 9, 2014. 10.1038/ejhg.2013.285.
49. Podlaha O., Riester M., De S., Michor F. Evolution of the cancer genome. Trends Genet. 2012, 28:155-163.
50. Poduri A., Evrony G.D., Cai X., Walsh C.A. Somatic mutation, genomic variation, and neurological disease. Science 2013, 341:1237758.
51. Qi J., Zhang X., Zhang H.K., Yang H.M., Zhou Y.B., Han Z.G. ZBTB34, a novel human BTB/POZ zinc finger protein, is a potential transcriptional repressor. Mol. Cell. Biochem. 2006, 290:159-167.
52. Quinlan A.R., Hall I.M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010, 26:841-842.
53. Tarsounas M., Tijsterman M. Genomes and G-quadruplexes: for better or for worse. J. Mol. Biol. 2013, 425:4782-4789.
54. Tomasetti C., Vogelstein B., Parmigiani G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc. Natl. Acad. Sci. USA 2013, 110:1999-2004.
55. van den Hurk J.A., Meij I.C., Seleme M.C., Kano H., Nikopoulos K., Hoefsloot L.H., Sistermans E.A., de Wijs I.J., Mukhopadhyay A., Plomp A.S., et al. L1 retrotransposition can occur early in human embryonic development. Hum. Mol. Genet. 2007, 16:1587-1592.
56. Voet T., Kumar P., Van Loo P., Cooke S.L., Marshall J., Lin M.L., Zamani Esteki M., Van der Aa N., Mateiu L., McBride D.J., et al. Single-cell paired-end genome sequencing reveals structural variation per cell cycle. Nucleic Acids Res. 2013, 41:6119-6138.
57. Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., Diaz L.A., Kinzler K.W. Cancer genome landscapes. Science 2013, 339:1546-1558.
58. Yang L., Luquette L.J., Gehlenborg N., Xi R., Haseley P.S., Hsieh C.H., Zhang C., Ren X., Protopopov A., Chin L., et al. Diverse mechanisms of somatic structural variations in human cancer genomes. Cell 2013, 153:919-929.
59. Youssoufian H., Pyeritz R.E. Mechanisms and consequences of somatic mosaicism in humans. Nat. Rev. Genet. 2002, 3:748-758.
60. Zack T.I., Schumacher S.E., Carter S.L., Cherniack A.D., Saksena G., Tabak B., Lawrence M.S., Zhang C.Z., Wala J., Mermel C.H., et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 2013, 45:1134-1140.
61. Zipfel P.F., Edey M., Heinen S., Józsi M., Richter H., Misselwitz J., Hoppe B., Routledge D., Strain L., Hughes A.E., et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 2007, 3:e41.